Bucillamine: Indication, Dosage, Side Effect, Precaution

This information is not country-specific. Please refer to the Myanmar prescribing information.

Generic Medicine Info

Indications and Dosage

Oral
Rheumatoid arthritis

Adult: Initially 100 mg/day.

Adverse Reactions

Skin and kidney disorders; pemiphigus lesions.

Action

Description: Bucillamine is structurally related to penicillamine & is reported to be an immunomodulator. It has been used in RA. It inhibits hypoxic induction of Vascular Endothelial Growth Factor (VEGF) through inhibition of Hypoxia Inducible Factor HIF-1 induction & binding activity in Bovine Retinal Microcapillary Endothelial Cells (BREC). It also inhibits the spontaneous expression of VEGF mRNA by its effect on Sp1 & Hypoxia Responsive Element (HRE) binding.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Disclaimer: This information is independently developed by MIMS based on Bucillamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com